| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 03/03/2004 | EP0948518B1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 03/03/2004 | EP0859628B9 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites |
| 03/03/2004 | CN1479788A Lactic acid bacteria capable of reducing indvidual's tendency to develop allergic reactions |
| 03/03/2004 | CN1479748A Anti-abnormal prion monoclonal antibody, process for producing the same and immunoassay method with the use thereof |
| 03/03/2004 | CN1478890A Fermented soya bean thromboembolism enzyme and polynucleotide for coding said enzyme |
| 03/03/2004 | CN1478550A Egg yolk antibody composition for preventing and treating atypical pneumonia and its preparation method |
| 03/03/2004 | CN1140536C Minotopes and anti-mimotopes of human platelet glycoprotein Ib/Ix |
| 03/03/2004 | CN1140295C Platelet-special chimeric immunoglobulin and method of use thereof |
| 03/02/2004 | US6699974 Reshaped human anti-HM 1.24 antibody |
| 03/02/2004 | US6699973 Gastro-intestinal tract (git); used to determine fate of drugs attached to git-targeting agents |
| 03/02/2004 | US6699972 Chimeric protein and method of controlling tumor growth using the protein |
| 03/02/2004 | US6699968 Fusion protein that includes a functional heparin sulfate attachment sequece placed into other proteins that normally do not have haparan sulfate glycosaminoglycan chains; links functional domains to biological effector molecules |
| 03/02/2004 | US6699967 Used to treat, prevent, or delay a tissue proliferation-associated disorder |
| 03/02/2004 | US6699965 Used for as a drug screening target; protein from rat and human brains |
| 03/02/2004 | US6699905 Comprising administering to the subject an effective anti-inflammatory amount of a pharmaceutical composition comprising a lipoxin a4 compound and a pharmaceutically acceptable carrier |
| 03/02/2004 | US6699715 Has variable heavy chain and a variable light chain which recognize and bind a cd28 receptor, fc region, and a portion of the transmembrane region of a b7 receptor, fusion protein; immunotherapy; single chain fv fragments (sfv) |
| 03/02/2004 | US6699694 Method for producing α-1,6-branched α-1,4-glucans from sucrose |
| 03/02/2004 | US6699678 Chlamydia trachomatis specific peptides and their use in diagnostic assays |
| 03/02/2004 | US6699673 Peptide for use in detection of methylated proteins |
| 03/02/2004 | US6699672 Heparanase specific molecular probes and their use research and medical applications |
| 03/02/2004 | US6699664 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 03/02/2004 | US6699660 Isolated nucleic acid identical to one expressed in response to seizure or ischemia |
| 03/02/2004 | US6699482 Leptospira rare outer membrane proteins |
| 03/02/2004 | US6699475 Recombinant pox virus for immunization against tumor-associated antigens |
| 03/02/2004 | US6699473 Human anti-epidermal growth factor receptor single-chain antibodies |
| 03/02/2004 | US6699472 Method of treating allergic disorders |
| 03/02/2004 | US6699466 IL-16 antagonist peptides and DNA encoding the peptides |
| 03/02/2004 | CA2149441C Activin receptor-like kinases, proteins having serine threonine kinase domains and their use |
| 03/02/2004 | CA2069960C Bispecific heteroantibodies with dual effector functions |
| 02/26/2004 | WO2004016790A1 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 02/26/2004 | WO2004016769A2 Antibodies directed to monocyte chemo-attractant protein-1 (mcp-1) and uses thereof |
| 02/26/2004 | WO2004016764A2 eNOS MUTANTS USEFUL FOR GENE THERAPY |
| 02/26/2004 | WO2004016753A2 Antibodies that immunospecifically bind to trail receptors |
| 02/26/2004 | WO2004016750A2 FcϜRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF |
| 02/26/2004 | WO2004016740A2 Humanized rabbit antibodies |
| 02/26/2004 | WO2004016739A2 Cell modulation using a cytoskeletal protein |
| 02/26/2004 | WO2004016655A1 ANTIBODY SPECIFIC TO CENTRAL τ-PROTEIN |
| 02/26/2004 | WO2004016285A1 Combination of tumor-associated surface protein antigens and tumor-associated sugars in the treatment and diagnosis of cancer |
| 02/26/2004 | WO2004016284A1 A method of immunomodulation |
| 02/26/2004 | WO2004016280A1 Recombinant bcg vaccine |
| 02/26/2004 | WO2004016231A2 PROTECTION OF PATIENTS LACKING A FUNCTIONAL SPLEEN AGAINST S. PNEUMONIAE WITH PNEUMOCOCCAL SURFACE PROTEIN A (PspA) |
| 02/26/2004 | WO2004016230A2 Identification of the endothelial receptor for the angiostatin kringle-5 |
| 02/26/2004 | WO2004016225A2 Compositions and methods for the diagnosis and treatment of tumor |
| 02/26/2004 | WO2004016222A2 Hepatitis c viral-like particle purification |
| 02/26/2004 | WO2004016151A2 Pthrp-derived modulators of smooth muscle proliferation |
| 02/26/2004 | WO2004016081A1 Method of expressing gene in transgenic birds using retrovirus vector and transgenic birds thus obtained |
| 02/26/2004 | WO2003104437A3 Anti-addl antibodies and uses thereof |
| 02/26/2004 | WO2003097688A3 Muteins of placental growth factor type 1, preparation method and application thereof |
| 02/26/2004 | WO2003093415A3 Methods useful in treatment and prevention of hiv infection |
| 02/26/2004 | WO2003091387A9 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
| 02/26/2004 | WO2003089614A3 Production of functional antibodies in filamentous fungi |
| 02/26/2004 | WO2003087841A3 An ephrin-b receptor protein involved in carcinoma |
| 02/26/2004 | WO2003086301A3 Antibodies that specifically bind to tr2 |
| 02/26/2004 | WO2003086296A3 Treatment for type 1 diabetes before and after expression of predisposition markers. |
| 02/26/2004 | WO2003074003A3 Immunogens for treatment of neoplastic and infectious disease |
| 02/26/2004 | WO2003073982A3 Anti-interleukin-1 beta analogs |
| 02/26/2004 | WO2003070894A3 A non-invasive diagnostic test utilizing histone modification markers |
| 02/26/2004 | WO2003059953B1 Anti-idiotypic antibody inducing hiv-1 neutralizing antibodies |
| 02/26/2004 | WO2003057829A3 Methods of generating multispecific, multivalent agents from vh and vl domains |
| 02/26/2004 | WO2003057715A3 Novel ligand involved in the transmigration of leukocytes . |
| 02/26/2004 | WO2003057014A9 Biomarkers for detecting ovarian cancer |
| 02/26/2004 | WO2003054019A3 Therapeutic monoclonal anti-tirc7 antibodies for use in immune related and other diseases |
| 02/26/2004 | WO2003049684A3 Pseudo-antibody constructs |
| 02/26/2004 | WO2003047420A3 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 02/26/2004 | WO2003046568A3 Protein biopolymer markers indicative of a disease state |
| 02/26/2004 | WO2003044482A3 Recombinant antibody fusion proteins and methods for detection of apoptotic cells |
| 02/26/2004 | WO2003044175A3 Methods and use of motoneuronotropic factors |
| 02/26/2004 | WO2003037247A3 Methods and pharmaceutical compositions for dopaminergic modulation of t-cell adhesion and acitivty |
| 02/26/2004 | WO2003035840A3 69583 and 85924, novel human protein kinase family members and uses therefor |
| 02/26/2004 | WO2003028543A3 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease |
| 02/26/2004 | WO2003011899A3 Antigenic polypeptides |
| 02/26/2004 | WO2003008449A8 Ntb-a, a surface molecule involved in natural killer cells activity |
| 02/26/2004 | WO2002103002A3 Gene associated with leishmania parasite virulence |
| 02/26/2004 | WO2002102973A3 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 02/26/2004 | WO2002092012A9 Compositions and methods for treating tumors bearing hmfg and cea antigens |
| 02/26/2004 | WO2002083917A8 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 02/26/2004 | WO2002078608A3 A simplified and improved method for preparing an antibody or an antibody fragment targeted immunoliposome or polyplex for systemic administration of a therapeutic or diagnostic agent |
| 02/26/2004 | WO2002072636A8 Crystals of whole antibodies and fragments thereof and methods for making and using them |
| 02/26/2004 | WO2002062204A3 Methods for diagnosing and treating heart disease |
| 02/26/2004 | WO2002051237A3 Helicobacter proteins, nucleic acids and uses thereof |
| 02/26/2004 | WO2002046418A3 Lipid-associated molecules |
| 02/26/2004 | WO2002046382A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/26/2004 | WO2002009576A3 Avian pneumovirus diagnostic system |
| 02/26/2004 | WO2001074299A3 Compositions and methods for inhibition of cancer invasion and angiogenesis |
| 02/26/2004 | WO2001057175A3 Methods and materials relating to neurotrimin-like polypeptides and polynucleotides |
| 02/26/2004 | US20040040059 Pectinophora gossypiella (pink bollworm) bacillus thuringiensis toxin receptor BT-R2 |
| 02/26/2004 | US20040039185 Novel family member of inhibitor of apoptosis proteins |
| 02/26/2004 | US20040039184 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 02/26/2004 | US20040039172 Relates to immunogen for inducing antibodies that neutralize a wide spectrum of HIV primary isolates and method of inducing anti-HIV antibodies using such immunogen |
| 02/26/2004 | US20040039166 Newly identified polypeptides and polynucleotides encoding such polypeptides referred to as inhibitor of apoptosis proteins (IAPL-3); use in diagnosis and in identifying compounds that may be agonists, antagonists |
| 02/26/2004 | US20040039164 Invention relates to identification and isolation of novel DNA and to recombinant production of novel polypeptides |
| 02/26/2004 | US20040038896 For diagnosis and therapy |
| 02/26/2004 | US20040038895 For diagnosis and therapy of respiratory and inflammatory diseases |
| 02/26/2004 | US20040038894 Useful for modulating an animal cell function involved in a disease selected from immunoproliferative diseases, immunodeficiency diseases, cancers, autoimmune diseases, infectious diseases, viral diseases, inflammatory response |
| 02/26/2004 | US20040038886 Chimeric cytoplasmic signalling molecules derived from cd137 |
| 02/26/2004 | US20040038879 For therapy and prophylaxis of infections such as bacterial, fungal, protozoan, and viral infections, particularly those caused by HIV viruses, pain, cancers, anorexia, bulimia, asthma, Parkinson's disease, acute heart failure |
| 02/26/2004 | US20040038877 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/26/2004 | US20040038876 For use in therapy and diagnosis |
| 02/26/2004 | US20040038874 Inhibiting the biochemical mediators of inflammation in a subject comprising administering to subject therapeutically effective dosage of inhibitor |
| 02/26/2004 | US20040038860 Reagents and methods for modulating dkk-mediated interactions |